Healthcare providers in the United States are well positioned to recognize substance use in their patients. Providers are also key in taking steps to address issues of substance use before it escalates to abuse. Unfortunately, substance use and abuse in adolescents remains undertreated in the United States. Early intervention in adolescents with substance use/abuse disorders is crucial in averting economic cost in this population group. This presentation will review treatment options for adolescents who present with various types of substance use disorders. Motivators for seeking treatment as well as gender and ethnicity will also be addressed. Barriers to treatment will also be discussed. | 1.50 credits CE/CME category 1 credits (1.50 Pharmacology) | $40

During the last 20 years, the rules and regulations regarding pain, opioid prescribing and opioid use disorder have changed significantly. Attendees will be taught the latest and most up-to-date information on DEA’s authority and background, licensing, registration, drug diversion, telemedicine, medication assistance treatment, nationwide opioid prescribing guidelines and case studies, along with learning risk mitigation strategies and best practices that will safeguard their practices. The instructor is a former DEA Special Agent with over 30 years of public service with real life prescription opioid experience. | 1.50 credits CE/CME category 1 credits (1.00 Pharmacology) | $40

This presentation will focus on the class of anxiolytics known as the benzodiazepines. Over the years, prescribers have had a love/hate relationship with these controlled substances. Upon completion of this presentation, participants will learn the benefits and risks related to the safe prescribing of benzodiazepines for individuals with various symptom presentations. The presentation will address the risks and cautions related to the prescribing of benzodiazepines with various medications, including the opioids and stimulants and in various healthcare settings. Participants also will receive tips to identify the warning signs of benzodiazepine abuse and techniques to safely taper and discontinue these medications to minimize the discomfort of withdrawal. | 1.50 credits CE/CME category 1 credits (1.50 Pharmacology) | $40